Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is a single center, randomized, open label crossover trial planned to include50 healthy participants to evaluate the relative bioavailability of HRS‐5346 new and oldformulations in healthy participants. The experimental process includes three stages:screening period, baseline period, and administration observation period.
Epistemonikos ID: c9f4479098b490cc25223fe6761429902056cad7
First added on: Aug 08, 2026